-
1di Kotsiou, Ourania S., Papagiannis, Dimitrios, Fradelos, Evangelos C., Siachpazidou, Dimitra I., Perlepe, Garifallia, Miziou, Angeliki, Kyritsis, Athanasios, Vavougios, George D., Kalantzis, Georgios, Gourgoulianis, Konstantinos I.“...Methods: The SARS-CoV-2 IgG II Quant method (Architect, Abbott, IL, USA) was used for antibody testing. ...”
Pubblicazione 2021
Testo
Testo
Testo
Online Articolo testo -
2di Kotsiou, Ourania S., Papagiannis, Dimitrios, Fradelos, Evangelos C., Perlepe, Garyfallia, Miziou, Angeliki, Siachpazidou, Dimitra S., Gourgoulianis, Konstantinos I.“...The Rapid Test 2019-nCoV Total Ig, V1210/V1230 (Prognosis Biotech, Greece), and the SARS-CoV-2 IgG II Quant method (Architect, Abbott, Illinois, USA) were used for antibody testing. ...”
Pubblicazione 2021
Testo
Testo
Testo
Online Articolo testo -
3di Kotsiou, Ourania S., Vavougios, George D., Papagiannis, Dimitrios, Matsiatsiou, Elena, Avgeri, Dimitra, Fradelos, Evangelos C., Siachpazidou, Dimitra I., Perlepe, Garifallia, Miziou, Angeliki, Kyritsis, Athanasios, Gogou, Eudoxia, Kalampokas, Serafim, Kalantzis, Georgios, Kotsios, Vaios S., Gourgoulianis, Konstantinos I.“...Methods: The SARS-CoV-2 IgG II Quant method (Architect, Abbott, IL, USA) was used for antibody testing. ...”
Pubblicazione 2022
Testo
Testo
Testo
Online Articolo testo -
4di Kotsiou, Ourania S., Karakousis, Nikolaos, Papagiannis, Dimitrios, Matsiatsiou, Elena, Avgeri, Dimitra, Fradelos, Evangelos C., Siachpazidou, Dimitra I., Perlepe, Garifallia, Miziou, Angeliki, Kyritsis, Athanasios, Gogou, Eudoxia, Vavougios, George D., Kalantzis, George, Gourgoulianis, Konstantinos I.“...The SARS-CoV-2 IgG II Quant method (Architect, Abbott, IL, USA) was used for antibody testing. ...”
Pubblicazione 2022
Testo
Testo
Testo
Online Articolo testo